Novo Holdings A/S Long-Term Concentrated

Location: Hellerup, Denmark

CIK: 0001388325 · Show all filings

Period: Q3 2018 (← Previous) (Next →)

Filing Date: Feb 6, 2019

Total Value: $1.26B (99.5% shares, 0.5% debt)

Holdings (23)

INGN INOGEN INC 68.8%
Value $866M Shares 3,549,320 Share Price $244.12 * Est. Cost/Share $17.78 Unrealized @ Report Date +1200.5%
GKOS GLAUKOS CORP 3.1%
Value $39.12M Shares 602,709 Share Price $64.90 * Est. Cost/Share $30.48 Unrealized @ Report Date +61.0%
CRVS CORVUS PHARMACEUTICALS INC 3.0%
Value $37.93M Shares 4,420,516 Share Price $8.58 * Est. Cost/Share $13.03 Unrealized @ Report Date -23.3%
— ACCELERON PHARMA INC 3.0%
Value $37.2M Shares 650,000 Share Price $57.23 Est. Cost/Share $27.65 Unrealized @ Report Date —
AKBA AKEBIA THERAPEUTICS INC 2.2%
Value $27.37M Shares 3,100,000 Share Price $8.83 Est. Cost/Share $12.34 Unrealized @ Report Date -27.5%
— AERIE PHARMACEUTICALS INC 2.0%
Value $25.15M Shares 408,562 Share Price $61.55 Est. Cost/Share $63.41 Unrealized @ Report Date —
— DERMIRA INC 1.9%
Value $24.5M Shares 1,993,746 Share Price $12.29 Est. Cost/Share $30.14 Unrealized @ Report Date —
KIDS ORTHOPEDIATRICS CORP 1.9%
Value $23.98M Shares 654,549 Share Price $36.64 * Est. Cost/Share $18.69 Unrealized @ Report Date +63.9%
— ENTASIS THERAPEUTICS HLDGS I 1.9%
Value $23.74M Shares 2,181,843 Share Price $10.88 Est. Cost/Share $10.88 Unrealized @ Report Date —
— MERUS N V 1.7%
Value $21.77M Shares 1,102,795 Share Price $19.74 Est. Cost/Share $7.99 Unrealized @ Report Date —
FOLD AMICUS THERAPEUTICS INC 1.6%
Value $19.92M Shares 1,647,870 Share Price $12.09 * Est. Cost/Share $14.73 Unrealized @ Report Date -5.0%
STIM NEURONETICS INC 1.3%
Value $16.83M Shares 525,000 Share Price $32.06 * Est. Cost/Share $30.40 Unrealized @ Report Date 0.0%
— SEASPINE HLDGS CORP 1.2%
Value $15.3M Shares 983,037 Share Price $15.56 Est. Cost/Share $10.44 Unrealized @ Report Date —
— MENLO THERAPEUTICS INC 1.1%
Value $14.15M Shares 1,436,313 Share Price $9.85 Est. Cost/Share $36.04 Unrealized @ Report Date —
— NABRIVA THERAPEUTICS PLC 1.0%
Value $12.7M Shares 4,703,720 Share Price $2.70 Est. Cost/Share $7.20 Unrealized @ Report Date —
GLPG GALAPAGOS NV 0.8%
Value $9.835M Shares 87,481 Share Price $112.42 Est. Cost/Share $112.42 Unrealized @ Report Date —
— VERONA PHARMA PLC 0.7%
Value $9.267M Shares 740,740 Share Price $12.51 Est. Cost/Share $11.66 Unrealized @ Report Date —
— INVUITY INC 0.7%
Value $8.953M Shares 1,209,854 Share Price $7.40 Est. Cost/Share $9.51 Unrealized @ Report Date —
— UNUM THERAPEUTICS INC 0.5%
Value $6.851M Shares 665,181 Share Price $10.30 Est. Cost/Share $47.61 Unrealized @ Report Date —
— WRIGHT MED GROUP N V 0.5%
Value $6.471M Shares 4,622,032 Share Price $1.40 Est. Cost/Share $1.25 Unrealized @ Report Date —
CRNX CRINETICS PHARMACEUTICALS IN 0.3%
Value $4.298M Shares 150,000 Share Price $28.65 * Est. Cost/Share $29.69 Unrealized @ Report Date 0.0%
— RA PHARMACEUTICALS INC 0.3%
Value $4.07M Shares 225,000 Share Price $18.09 Est. Cost/Share $15.19 Unrealized @ Report Date —
C CITIGROUP INC 0.3%
Value $3.766M Shares 52,500 Share Price $71.73 * Est. Cost/Share $53.03 Unrealized @ Report Date +3.3%